Search results for "Parkin"

showing 10 items of 468 documents

E163L HOMOZYGOUS DJ-1 MUTATION IN A FAMILY FROM SOUTHERN ITALY WITH AMIOTROPHIC LATERAL SCLEROSIS-PARKINSONISM-DEMENTIA COMPLEX.

2004

Parkinson disease mutation genetic parkinsonism
researchProduct

The Cumulative Effect of Transient Synchrony States on Motor Performance in Parkinson's Disease.

2020

Bursts of beta frequency band activity in the basal ganglia of patients with Parkinson's disease (PD) are associated with impaired motor performance. Here we test in human adults whether small variations in the timing of movement relative to beta bursts have a critical effect on movement velocity and whether the cumulative effects of multiple beta bursts, both locally and across networks, matter.

0301 basic medicineMaleParkinson's diseaseBehavioral/CognitiveParkinson's diseaseDeep Brain StimulationElectroencephalography Phase Synchronization610 Medicine & healthLocal field potentialHypokinesialocal field potentialsBasal Ganglia03 medical and health sciencesBursting0302 clinical medicineSubthalamic NucleusBasal gangliaMedicineHumansBeta (finance)610 Medicine & healthCumulative effectResearch ArticlesAgedCued speechbeta oscillationsbusiness.industryGeneral NeuroscienceParkinson DiseaseMiddle Agedmedicine.diseaseSubthalamic nucleus030104 developmental biologyFemaleCuesbusinessBeta RhythmNeuroscience030217 neurology & neurosurgeryPhotic StimulationPsychomotor Performance
researchProduct

Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota.

2019

With the rise of Next-Generation-Sequencing (NGS) methods, Micro-RNAs (miRNAs) have achieved an important position in the research landscape and have been found to present valuable diagnostic tools in various diseases such as multiple sclerosis or lung cancer. There is also emerging evidence that miRNAs play an important role in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease (AD) or Parkinson’s disease (PD). Apparently, these diseases come along with changes in miRNA expression patterns which led to attempts from researchers to use these small RNA species from several body fluids for a better diagnosis and in order to observe disease progression. Additionally, it…

610 Medical sciencesmicro-RNAsneurodegenerationParkinson’s disease610 Medizingut microbiomeAlzheimer’s diseaselcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNeuroscienceOriginal Researchcrosstalklcsh:RC321-571Frontiers in neuroscience
researchProduct

Determinants of depressive symptoms among spouse caregivers of patients with Parkinson's disease

2004

Parkinson
researchProduct

Disentangling the Amyloid Pathways: A Mechanistic Approach to Etiology

2020

Amyloids are fibrillar protein aggregates associated with diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), type II diabetes and Creutzfeldt–Jakob disease. The process of amyloid polymerization involves three pathological protein transformations; from natively folded conformation to the cross-β conformation, from biophysically soluble to insoluble, and from biologically functional to non-functional. While amyloids share a similar cross-β conformation, the biophysical transformation can either take place spontaneously via a homogeneous nucleation mechanism (HON) or catalytically on an exogenous surface via a heterogeneous nucleation mechanism (HEN). Here, we postulate that…

prionnucleationmental disordersamyloidvirusAlzheiemr’sParkinson’slcsh:Neurosciences. Biological psychiatry. Neuropsychiatrylcsh:RC321-571Frontiers in Neuroscience
researchProduct

COGNITIVE IMPAIRMENT IN PATIENTS WITH PARKINSON’S DISEASE

2011

Settore MED/26 - NeurologiaCOGNITIVE IMPAIRMENTPARKINSON’S DISEASE
researchProduct

Frequency-specific network activity predicts bradykinesia severity in Parkinson’s disease

2021

Highlights • Parallel subnetworks are affected in bradykinesia. • The primary motor and the premotor cortex are common nodes with task-specificity. • Beta activity decreases, gamma activity increases with improvement of bradykinesia. • Subthalamic stimulation reduces beta, increases gamma power in ipsilateral cortex. • Subnetworks act with frequency-specific oscillations.

PPC posterior parietal cortexBradykinesiaParkinson's diseaseDeep brain stimulationCognitive Neurosciencemedicine.medical_treatmentComputer applications to medicine. Medical informaticsR858-859.7FT finger tappingHypokinesiaElectromyographyElectroencephalographyPS pronation-supinationGamma oscillationPremotor cortexCER cerebellumSubthalamic NucleusDeep brain stimulationmedicineHumansRadiology Nuclear Medicine and imagingRC346-429SMA supplementary motor cortexM1 primary motor cortexResting state fMRImedicine.diagnostic_testbusiness.industryRegular ArticleBeta oscillationmedicine.diseasehumanitiesnervous system diseasesParkinson diseaseHG hand graspingSubthalamic nucleusCross-Sectional Studiesmedicine.anatomical_structurePMC premotor cortexNeurologyDLPFC dorsolateral prefrontal cortexFinger tappingStrEM structural equation modellingNeurology. Diseases of the nervous systemNeurology (clinical)businessNeuroscienceSTN subthalamic nucleusNeuroImage: Clinical
researchProduct

Objective assessment of blinking and facial expressions in Parkinson’s disease using a vertical electro-oculogram and facial surface electromyography

2019

Objective: Hypomimia is a common and early symptom of Parkinson's disease (PD), which reduces the ability of PD patients to manifest emotions. Currently, it is visually evaluated by the neurologist during neurological examinations for PD diagnosis, as described in task 3.2 of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Since such an evaluation is semi-quantitative and affected by inter-variability, this paper aims to measure the physiological parameters related to eye blink and facial expressions extracted from a vertical electro-oculogram (VEOG) and facial surface electromyography (fsEMG) to differentiate PD patients from healthy control subjects (…

Malemedicine.medical_specialtyvertical electro-oculogramParkinson's diseasegenetic structuresPhysiologyParkinson's disease0206 medical engineeringElectro oculogramBiomedical EngineeringBiophysicsHypomimia02 engineering and technologyElectromyographyAudiologyObjective assessment03 medical and health sciences0302 clinical medicineRating scalePhysiology (medical)spontaneous eye blink rateHumansMedicineElectrodesAgedFacial expressionBlinkingmedicine.diagnostic_testElectromyographybusiness.industryParkinson DiseaseSignal Processing Computer-AssistedElectrooculographymedicine.disease020601 biomedical engineeringfacial surface emgFacial ExpressionElectrooculographyROC CurveArea Under CurveCase-Control StudiesFemalemedicine.symptombusiness030217 neurology & neurosurgeryPhysiological Measurement
researchProduct

Role of serotonin in central dopamine dysfunction

2010

The interaction between serotonin (5-HT) and dopamine (DA)-containing neurons in the brain is a research topic that has raised the interest of many scientists working in the field of neuroscience since the first demonstration of the presence of monoamine-containing neurons in the mid 1960. The bulk of neuroanatomical data available clearly indicate that DA-containing neurons in the brain receive a prominent innervation from serotonin (5-hydroxytryptamine, 5-HT) originating in the raphe nuclei of the brainstem. Compelling electrophysiological and neurochemical data show that 5-HT can exert complex effects on the activity of midbrain DA neurons mediated by its various receptor subtypes. The m…

Mesocorticolimbic DA systemNigrostriatal DA systemReceptor Serotonin 5-HTParkinson's diseaseBrain microdialysisAntidepressantDopaminergic functionAntidepressantsSettore BIO/09 - Fisiologia5-HT receptorAntipsychoticParkinson diseaseMicrodialysinervous systemSingle cell recordingDrug addictionAntidepressants;Antipsychotics;Dopaminergic function;Drug addiction;5-HT receptors;Mesocorticolimbic DA system;Microdialysis;Nigrostriatal DA system;Parkinson disease;Single cell recordingAntipsychotic drugs
researchProduct

Amorphous Ropinirole-Loaded Mucoadhesive Buccal Film: A Potential Patient-Friendly Tool to Improve Drug Pharmacokinetic Profile and Effectiveness

2020

Nowadays the therapeutic strategies to manage Parkinson&rsquo

Drugtherapy optimizationparkinson’s diseasemedia_common.quotation_subjectPeppas-Salhin model.Medicine (miscellaneous)orocomucosal filmslcsh:MedicinePeppas-Salhin model02 engineering and technologyPharmacology030226 pharmacology & pharmacyDosage formArticleorocomucosal film03 medical and health sciencesdissolution kinetic0302 clinical medicinebuccal administrationPharmacokineticsOral administrationSettore MED/28 - Malattie OdontostomatologicheMucoadhesionMedicineEudragit® L100media_commonbusiness.industrylcsh:Rex vivo permeationBuccal administration021001 nanoscience & nanotechnologynervous system diseasesropiniroleRopiniroleSettore CHIM/09 - Farmaceutico Tecnologico Applicativo0210 nano-technologybusinessDrug metabolismdissolution kineticsmucoadhesionmedicine.drug
researchProduct